Cullin 3 mediates SRC-3 ubiquitination and degradation to control the retinoic acid response

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 51, 2011, Pages 20603-20608

  Ferry, Christine ^a   Gaouar, Samia ^a   Fischer, Benoit ^a   Boeglin, Marcel ^a   Paul, Nicodeme ^a   Samarut, Eric ^a   Piskunov, Aleksandr ^a   Pankotai Bodo, Gabriella ^a   Brino, Laurent ^a   Rochette Egly, Cecile ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CULLIN; CULLIN 3; PROTEIN; RBX1 PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR; SERINE; SRC 3 PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE CONTROL; GENETIC TRANSCRIPTION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; UBIQUITINATION;

ANIMALS; BINDING SITES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; CHROMATIN; COS CELLS; CULLIN PROTEINS; HUMANS; MICROSCOPY, FLUORESCENCE; NUCLEAR RECEPTOR COACTIVATOR 3; PHOSPHORYLATION; TRANSCRIPTION, GENETIC; TRETINOIN; UBIQUITIN;

EID: 84855510640     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1102572108     Document Type: Article

References (28)

1. Rochette-Egly C, Germain P (2009) Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors. Nucl Recept Signal 7:e005.
2. Han SJ, Lonard DM, O'Malley BW (2009) Multi-modulation of nuclear receptor coactivators through posttranslational modifications. Trends Endocrinol Metab 20:8-15.
3. O'Malley BW, Qin J, Lanz RB (2008) Cracking the coregulator codes. Curr Opin Cell Biol 20:310-315.
4. Wu RC, Feng Q, Lonard DM, O'Malley BW (2007) SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock. Cell 129:1125-1140. (Pubitemid 46891039)
5. Wu RC, et al. (2004) Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. Mol Cell 15:937-949.
6. Giannì M, et al. (2006) P38MAPK-dependent phosphorylation and degradation of SRC-3/AIB1 and RARalpha-mediated transcription. EMBO J 25:739-751. (Pubitemid 43292436)
7. Ferry C, et al. (2009) SUG-1 plays proteolytic and non-proteolytic roles in the control of retinoic acid target genes via its interaction with SRC-3. J Biol Chem 284:8127-8135.
8. Mani A, et al. (2006) E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells. Cancer Res 66:8680-8686. (Pubitemid 44449184)
9. Petroski MD, Deshaies RJ (2005) Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 6:9-20. (Pubitemid 40064895)
10. Spoel SH, et al. (2009) Proteasome-mediated turnover of the transcription coactivator NPR1 plays dual roles in regulating plant immunity. Cell 137:860-872.
11. Zhang Q, et al. (2009) Multiple Ser/Thr-rich degrons mediate the degradation of Ci/Gli by the Cul3-HIB/SPOP E3 ubiquitin ligase. Proc Natl Acad Sci USA 106:21191-21196.
12. Xing H, Hong Y, Sarge KD (2010) PEST sequences mediate heat shock factor 2 turnover by interacting with the Cul3 subunit of the Cul3-RING ubiquitin ligase. Cell Stress Chaperones 15:301-308.
13. Bruck N, et al. (2009) A coordinated phosphorylation cascade initiated by p38MAPK/MSK1 directs RARalpha to target promoters. EMBO J 28:34-47.
14. Piskunov A, Rochette-Egly C (2011) A retinoic acid receptor RARα pool present in membrane lipid rafts forms complexes with G protein αQ to activate p38MAPK. Oncogene, in press.
15. Söderberg O, et al. (2006) Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods 3:995-1000. (Pubitemid 44782698)
16. Welcker M, Larimore EA, Frappier L, Clurman BE (2011) Nucleolar targeting of the fbw7 ubiquitin ligase by a pseudosubstrate and glycogen synthase kinase 3. Mol Cell Biol 31:1214-1224.
17. Tari AM, Lim SJ, Hung MC, Esteva FJ, Lopez-Berestein G (2002) Her2/neu induces all-trans retinoic acid (ATRA) resistance in breast cancer cells. Oncogene 21:5224-5232. (Pubitemid 34948134)
18. Xu J, Wu RC, O'Malley BW (2009) Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat Rev Cancer 9:615-630.
19. van den Heuvel S (2004) Protein degradation: CUL-3 and BTB - partners in proteolysis. Curr Biol 14:R59-R61.
20. Stogios PJ, Downs GS, Jauhal JJ, Nandra SK, Privé GG (2005) Sequence and structural analysis of BTB domain proteins. Genome Biol 6:R82.
21. Hao B, Oehlmann S, Sowa ME, Harper JW, Pavletich NP (2007) Structure of a Fbw7-Skp1-cyclin E complex: Multisite-phosphorylated substrate recognition by SCF ubiquitin ligases. Mol Cell 26:131-143. (Pubitemid 46550934)
22. Samarut E, et al. (2011) Evolution of nuclear retinoic acid receptor alpha (RARα) phosphorylation sites. Serine gain provides fine-tuned regulation. Mol Biol Evol 28:2125-2137.
23. Li C, et al. (2011) Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3/AIB1. Oncogene 30:4350-4364.
24. Blume-Jensen P, Hunter T (2001) Oncogenic kinase signalling. Nature 411:355-365. (Pubitemid 32467045)
25. Emanuele MJ, et al. (2011) Global identification of modular cullin-RING ligase substrates. Cell 147:459-474.
26. Hua S, Kittler R, White KP (2009) Genomic antagonism between retinoic acid and estrogen signaling in breast cancer. Cell 137:1259-1271.
27. Ross-Innes CS, et al. (2010) Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer. Genes Dev 24:171-182.
28. Darro F, et al. (1998) Growth inhibition of human in vitro and mouse in vitro and in vivo mammary tumor models by retinoids in comparison with tamoxifen and the RU-486 anti-progestagen. Breast Cancer Res Treat 51:39-55. (Pubitemid 28550159)